Go offline with the Player FM app!
1.16 - Prof David Nutt: The Neuroscience Of Psychedelics, Addiction, And How Drugs Help Us Understand The Brain
Manage episode 301934562 series 2896878
Prof David Nutt is Neuropsychopharmacologist specialising in the research of drugs that affect the brain and conditions such as addiction, anxiety, and sleep.
David is the chairman of Drug Science, a non-profit which he founded in 2010 to provide independent, evidence-based information on drugs. Nutt is the deputy head of the Centre for Psychedelic Research at Imperial College London. He and his team have published research into psilocybin for TRD, as well as neuroimaging studies investigating psilocybin, MDMA, LSD, and DMT.
In this episode:
- How drugs help our understanding of the brain
- Impact of prohibition on investigation and research
- Key terms - decriminalisation, depenalisation, legalisation
- Drug harm profiles - alcohol, lsd, mdma, psilocybin
- Physiology and psychology of addiction
- Brain-mind interplay
- The psychedelic experience and its phenomena
- The default mode network
- Functional connectivity
- Neuroplasticity
- Why profound alterations in consciousness permit long-term changes
- Serotonin's role in depression
- Psilocybin vs SSRIs and the 5HT2a receptor
- Psychedelics vs Psychedelic-assisted psychotherapies
Links:
Recent paper exploring Psilocybin vs SSRIs:
Serotonin and brain function: a tale of two receptors
Support the podcast:
Support the mission:
Donate to Mind Medicine Australia
Support this show http://supporter.acast.com/mind-medicine-australia.
Become a member at https://plus.acast.com/s/mind-medicine-australia.
Hosted on Acast. See acast.com/privacy for more information.
41 episodes
Manage episode 301934562 series 2896878
Prof David Nutt is Neuropsychopharmacologist specialising in the research of drugs that affect the brain and conditions such as addiction, anxiety, and sleep.
David is the chairman of Drug Science, a non-profit which he founded in 2010 to provide independent, evidence-based information on drugs. Nutt is the deputy head of the Centre for Psychedelic Research at Imperial College London. He and his team have published research into psilocybin for TRD, as well as neuroimaging studies investigating psilocybin, MDMA, LSD, and DMT.
In this episode:
- How drugs help our understanding of the brain
- Impact of prohibition on investigation and research
- Key terms - decriminalisation, depenalisation, legalisation
- Drug harm profiles - alcohol, lsd, mdma, psilocybin
- Physiology and psychology of addiction
- Brain-mind interplay
- The psychedelic experience and its phenomena
- The default mode network
- Functional connectivity
- Neuroplasticity
- Why profound alterations in consciousness permit long-term changes
- Serotonin's role in depression
- Psilocybin vs SSRIs and the 5HT2a receptor
- Psychedelics vs Psychedelic-assisted psychotherapies
Links:
Recent paper exploring Psilocybin vs SSRIs:
Serotonin and brain function: a tale of two receptors
Support the podcast:
Support the mission:
Donate to Mind Medicine Australia
Support this show http://supporter.acast.com/mind-medicine-australia.
Become a member at https://plus.acast.com/s/mind-medicine-australia.
Hosted on Acast. See acast.com/privacy for more information.
41 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.